Phase 3 Migraine Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- Your child weighs at least 44 lbs (20 kg) and less than 298 lbs (135 kg).
- Your child has had episodic migraines (with or without visual or sensory warning signs called "aura") for at least 6 months.
- During the 28-day tracking period before the trial, your child had between 4 and 14 migraine days, and fewer than 15 headache days total.
- For a specific part of the study looking at how the body processes the medication, your child must be between 6 and 11 years old, have a history of migraines, and the doctor must agree that preventive migraine treatment is appropriate for them.
Who may not be able to join:
- Your child has a history of certain specific types of migraine, including migraines that affect brainstem function, migraines that cause temporary paralysis on one side of the body (hemiplegic migraine), or migraines that affect vision in one eye (retinal migraine) (confirm with trial site).
- Your child currently has chronic migraine, meaning they have very frequent migraines on most days of the month (confirm with trial site).
- Your child has been diagnosed with certain other types of persistent or severe head pain conditions, such as daily non-stop headaches, cluster headaches, or nerve-related facial pain (confirm with trial site).
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: ABBVIE INC., AbbVie
Phone: 844-663-3742
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Change from Baseline in Mean Monthly Migraine Days; Number of Participants Experiencing Adverse Events
Can't join this trial?
Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.